MedTrace Logo

Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication

NCT02660619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 606

Last updated 2020-06-16

No results posted yet for this study

Summary

The purpose is to validate the PRISM-5-Op as a measurement of prescription opioid substance use disorder.

Conditions

  • Opioid-Related Disorders
  • Opiate Addiction
  • Narcotic Abuse
  • Drug Abuse

Interventions

OTHER

Psychiatric Research Interview for Substance and Mental Disorders (PRISM-5-Op)

Sponsors & Collaborators

  • Research Foundation for Mental Hygiene, Inc.

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Member Companies of the Opioid PMR Consortium

    lead INDUSTRY

Principal Investigators

  • Kenneth R Petronis · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-17
Primary Completion
2017-11-28
Completion
2017-11-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660619 on ClinicalTrials.gov